Hemophilia primary prevention

	Hemophilia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hemophilia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hemophilia primary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hemophilia primary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hemophilia primary prevention
CDC on Hemophilia primary prevention
Hemophilia primary prevention in the news
Blogs on Hemophilia primary prevention
Directions to Hospitals Treating Hemophilia
Risk calculators and risk factors for Hemophilia primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sabawoon Mirwais, M.B.B.S, M.D.[2]

Overview

Primary prevention of hemophilia encompasses measures taken to raise awareness regarding the genetics of the disease and the genetic transmission of the condition. Having an X-linked mode of transmission, genetic counselling in female carriers and awareness are the main focus for the primary prevention of hemophilia.

Primary prevention of hemophilia encompasses measures taken to raise awareness regarding the genetics of the disease.
Genetic counselling in female carriers is the main focus for the primary prevention of hemophilia.^[1]^[2]
Women who are carriers, may require and benefit from several rounds of genetic counselling at different stages of life.^[3]

↑ Jourdy Y, Chatron N, Fretigny M, Carage ML, Chambost H, Claeyssens-Donadel S, Roussel-Robert V, Negrier C, Sanlaville D, Vinciguerra C (July 2017). "Molecular cytogenetic characterization of five F8 complex rearrangements: utility for haemophilia A genetic counselling". Haemophilia. 23 (4): e316–e323. doi:10.1111/hae.13218. PMID 28475226.
↑ Oldenburg J, Pezeshkpoor B, Pavlova A (November 2014). "Historical review on genetic analysis in hemophilia A". Semin. Thromb. Hemost. 40 (8): 895–902. doi:10.1055/s-0034-1395161. PMID 25377322.
↑ von der Lippe C, Frich JC, Harris A, Solbrække KN (December 2017). ""It was a lot Tougher than I Thought It would be". A Qualitative Study on the Changing Nature of Being a Hemophilia Carrier". J Genet Couns. 26 (6): 1324–1332. doi:10.1007/s10897-017-0112-9. PMID 28547664.